MedAvail

MedAvail is a company listed under the stock ticker MDVL (CA).

View the org chart displaying its 13 main executives

Most searched biographies at MedAvail

• Mark Doerr, Chief Executive Officer
• Michael Kramer, Director
• Rob Faulkner, Chairman of the Board

Create your alert
to follow the executive moves at MedAvail.

MedAvail has 1,861 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• MedMen has filed for bankruptcy protection  (posted on April 28 2024).
• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma
• Emma Walmsley - Chief Executive Officer and Director at GSK

Learn more about the Pharmaceuticals industry >

Press releases by MedAvail

• In the news - Page 2 of 2 - Medavail
• In the news - Medavail
• News - MedAvail
• MedAvail completes financing round, adds Express Scripts as new investor - MedAvail

Social media about MedAvail

• MedAvail on Wikipedia, Google News & Yahoo Finance
• MedAvail on LinkedIn, Twitter & YouTube

Contact by email its executives including Mark Doerr

Call MedAvail at +1 877...

View the org chart

Register to receive your alert

Report an error